Strategic Initiative

Slingshot members are tracking this corporate initiative:

CareDx and QIAGEN Enter Into Commercial Collaboration to Enhance HLA Lab Experience Using QIAxcel Instrumentation and CareDx HLA Typing Technology

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
CDNA Community voting in process
QGEN Community voting in process

Additional Information

Additional Relevant Details
Under the terms of this commercial collaboration, CareDx will make available to Human Leukocyte Antigen (HLA) laboratories worldwide the proprietary QIAGEN QIAxcel Advanced Instrumentation together with its proprietary Olerup SSP kits and SCORE software. This combined offering will provide transplant labs an additional option for processing and data entry for HLA typing.
http://investors.car...
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date:
May 31, 2016
Projected Implementation:
Q2, 2016
Relevance Tracked Until:
Q4, 2016
Related Projects Image
  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Score Software, Olerup Ssp Kits, Qiagen Qiaxcel Advanced Instrumentation, Human Leukocyte Antigen